Influence of arthritis-related protein (BBF01) on infectivity of Borrelia burgdorferi B31

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Imai, Denise ^a   Holden, Kevin ^a   Velazquez, Eric M ^a   Feng, Sunlian ^a   Hodzic, Emir ^a   Barthold, Stephen W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arthritis related protein; BBF01; Lyme borreliosis

Indexed keywords

BACTERIAL PROTEIN; BBF01 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; CONTROLLED STUDY; GENE DELETION; GENETIC COMPLEMENTATION; HOST PATHOGEN INTERACTION; INFECTION SENSITIVITY; LYME DISEASE; MOLECULARLY TARGETED THERAPY; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPIC VARIATION; SCID MOUSE; SPIROCHETE; TICK; WILD TYPE;

ANIMAL STRUCTURES; ANIMALS; BACTERIAL LOAD; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; DISEASE VECTORS; FEMALE; GENE DELETION; GENETIC COMPLEMENTATION TEST; LYME DISEASE; MICE; MICE, INBRED C3H; PREGNANCY; TICKS; VIRULENCE FACTORS;

BORRELIA BURGDORFERI; IXODIDA; MUS; SPIROCHAETALES;

EID: 84877019130     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-100     Document Type: Article

References (43)

1. The clinical evolution of Lyme arthritis. Steere AC, Schoen RT, Taylor E, Ann Intern Med 1987 107 725 731 10.7326/0003-4819-107-5-725 3662285
2. The emergence of Lyme disease. Steere AC, Coburn J, Glickstein L, J Clin Invest 2004 113 1093 1101 15085185
3. Lyme disease. Steere AC, N Engl J Med 1989 321 586 596 10.1056/NEJM198908313210906 2668764
4. Chronic Lyme borreliosis in the laboratory mouse. Barthold SW, de Souza MS, Janotka JL, Smith AL, Persing DH, Am J Pathol 1993 143 3 951 971
5. T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. McKisic MD, Barthold SW, Infect Immun 2000 68 5190 5197 10.1128/IAI.68.9.5190-5197.2000 10948143
6. Serum-mediated resolution of Lyme arthritis in mice. Barthold SW, de Souza M, Feng S, Lab Invest 1996 74 57 67 8569198
7. Protective and arthritis- resolving activity in serum from mice infected with Borrelia burgdorferi. Barthold SW, Feng S, Bockenstedt LK, Fikrig E, Feen K, Clin Infect Dis 1997 25 9 S17 10.1086/516166 9233658
8. Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Barthold SW, Hodzic E, Tunev S, Feng S, Infect Immun 2006 74 4817 4825 10.1128/IAI.00469-06 16861670
9. Borrelia burgdorferi genes selectively expressed in ticks and mammals. de Silva AM, Fikrig E, Parasit Today 1997 13 267 270 10.1016/S0169-4758(97)01074-0
10. Arthropod- and host-specific gene expression by Borrelia burgdorferi. de Silva AM, Fikrig E, J Clin Invest 1997 99 377 379 10.1172/JCI119169 9022068
11. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Feng S, Hodzic E, Stevenson B, Barthold SW, Infect Immun 1998 66 2827 2835 9596756
12. Lyme arthritis resolution with antiserum to a 37- kilodalton Borrelia burgdorferi protein. Feng S, Hodzic E, Barthold SW, Infect Immun 2000 68 4169 4173 10.1128/IAI.68.7.4169-4173.2000 10858233
13. Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Fikrig E, Chen M, Barthold SW, Anguita J, Feng W, TelfordIII SR, Flavell RA, Mol Microbiol 1999 31 281 290 10.1046/j.1365-2958.1999.01171.x 9987129
14. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Hook M, Infect Immun 1998 66 2143 2153 9573101
15. Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Hagman KE, Yang X, Wikel SK, Schoeler GB, Caimano MJ, Radolph JD, Norgard MV, Infect Immun 2000 68 4759 4764 10.1128/IAI.68.8.4759-4764.2000 10899883
16. Immunogenicity of Borrelia burgdorferi arthritis-related protein. Feng S, Hodzic E, Freet K, Barthold SW, Infect Immun 2003 71 7211 7214 10.1128/IAI.71.12.7211-7214.2003 14638819
17. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. Liang FT, Jacobs MB, Bowers LC, Philipp MT, J Exp Med 2002 195 415 422 10.1084/jem.20011870 11854355
18. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Zhong W, Gern L, Stehle T, Museteanu C, Kramer M, Wallich R, Simon MM, Eur J Immunol 1999 29 946 957 10.1002/(SICI)1521-4141(199903)29:03<946::AID-IMMU946>3.0. CO;2-P 10092099
19. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Hodzic E, Feng S, Freet KJ, Borjesson DL, Barthold SW, Infect Immun 2002 70 3382 3388 10.1128/IAI.70.7.3382-3388.2002 12065476
20. Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi. Salazar CA, Rothemich M, Drouin EE, Glickstein L, Steere AC, Infect Immun 2005 73 2951 2957 10.1128/IAI.73.5.2951-2957.2005 15845501
21. Lymphadenopathy during Lyme borreliosis is caused by spirochete migration- induced specific B cell activation. Tunev SS, Hastey CJ, Hodzic E, Feng S, Barthold SW, Baumgarth N, PLoS Pathog 2011 7 1002066 10.1371/journal.ppat.1002066 21637808
22. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Hodzic E, Feng S, Freet K, Barthold SW, Infect Immun 2003 71 5042 5055 10.1128/IAI.71.9.5042-5055. 2003 12933847
23. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E, Infect Immun 2004 72 5759 5767 10.1128/IAI.72.10.5759-5767. 2004 15385475
24. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Probert WS, LeFebvre RB, Infect Immun 1994 62 1920 1926 8168958
25. The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Bankhead T, Chaconas G, Mol Microbiol 2007 65 1547 1558 10.1111/j.1365-2958.2007.05895.x 17714442
26. The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Labandeira-Rey M, Seshu J, Skare J, Infect Immun 2003 71 4608 4613 10.1128/IAI.71.8.4608-4613.2003 12874340
27. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Labandeira-Rey M, Skare JT, Infect Immun 2001 69 446 455 10.1128/IAI.69.1.446-455.2001 11119536
28. Correlation between plasmid content and infectivity of Borrelia burgdorferi. Purser JE, Norris SJ, Proc Natl Acad Sci USA 2000 97 13865 13870 10.1073/pnas.97.25.13865 11106398
29. Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Xu Q, Seemanapalli SV, Lomax L, McShan K, Li X, Fikrig E, Liang FT, Infect Immun 2005 73 7208 7215 10.1128/IAI.73.11.7208-7215.2005 16239515
30. Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. Pal U, Wang P, Bao F, Yang X, Samanta S, Schoen R, Wormser GP, Schwartz I, Fikrig E, J Exp Med 2008 205 133 141 10.1084/jem.20070962 18166585
31. MyD88 deficiency enhances acquisition and transmission of Borrelia burgdorferi by Ixodes scapularis ticks. Bockenstedt LK, Liu N, Schwartz I, Fish D, Infect Immun 2006 74 2154 2160 10.1128/IAI.74.4.2154-2160.2006 16552045
32. Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-agent interface. Hodzic E, Borjesson DL, Feng S, Barthold SW, Vector Borne Zoonotic Dis 2001 1 149 158 10.1089/153036601316977750 12680352
33. Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Kung F, Anguita J, Pal U, Future Microbiol 2013 8 41 56 10.2217/fmb.12.121 23252492
34. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Armstrong AL, Barthold SW, Persing DH, Beck DS, Am J Trop Med Hyg 1992 47 2 249 258 1503192
35. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Barthold SW, Sidman CL, Smith AL, Am J Trop Med Hyg 1992 47 605 613 1449201
36. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, et al. Mol Microbiol 2000 35 490 516 10672174
37. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, et al. Nature 1997 390 580 586 10.1038/37551 9403685
38. Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Grimm D, Eggers CH, Caimano MJ, Tilly K, Stewart PE, Elias AF, Radolf JD, Rosa PA, Infect Immun 2004 72 5938 5946 10.1128/IAI.72.10.5938-5946.2004 15385497
39. Isolation and cultivation of Lyme disease spirochetes. Barbour AG, Yale J Biol Med 1984 57 521 525 6393604
40. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB. Samuels DS, Mach KE, Garon CF, J Bacteriol 1994 176 6045 6049 7928965
41. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Ohnishi J, Piesman J, de Silva A, Proc Natl Acad Sci USA 2001 98 670 675 10.1073/pnas.98.2.670 11209063
42. Kinetics of Borrelia burgdorferi dissemination and evolution of disease following intradermal inoculation of mice. Barthold SW, Persing DH, Armstrong AL, Peeples RA, Am J Pathol 1991 139 263 273 1867318
43. A simple method of estimating fifty per cent endpoints. Reed LJ, Muench H, Am J Hyg 1938 27 493 497 of Allergy and Infectious Diseases of Allergy and Infectious Diseases